Absence of HBV Reactivation in Patients With Resolved HBV Infection Following DAA Therapy for Hepatitis C: A 1-Year Follow-up Study.
Marcus Maximilian MückeVictoria T MückeKai-Henrik PeifferChristoph SarrazinStefan ZeuzemAnnemarie BergerJohannes VermehrenPublished in: Open forum infectious diseases (2018)
Our results indicate that the risk of HBV-R in patients with resolved HBV treated with DAAs for HCV is low during long-term follow-up.